Featured Research

from universities, journals, and other organizations

Cancer drug linked to quantum dots increases drug uptake, reduces inflammation

Date:
November 3, 2010
Source:
University at Buffalo
Summary:
Researchers have developed a novel technology using quantum dots that is expected to have major implications for research and treatment of tuberculosis, as well as other inflammatory lung diseases.

The left image shows lung tissue injected with doxorubicin alone, while the image on the right (yellow dots) indicates the increased uptake of the quantum-dot delivered drug.
Credit: Image courtesy of University at Buffalo

Researchers at the University at Buffalo have developed a novel technology using quantum dots that is expected to have major implications for research and treatment of tuberculosis, as well as other inflammatory lung diseases.

A paper appearing online in Nanomedicine: Nanotechnology, Biology and Medicine as an article-in-press describes specific delivery of a chemotherapeutic drug to specific cells in the lung, particularly the alveolar white cell, without causing acute inflammation.

Quantum dots are tiny semiconductor particles generally no larger than 10 nanometers that can be made to fluoresce in different colors depending on their size. Scientists are interested in quantum dots because they are a superb carrier and last much longer than conventional dyes used to tag molecules, which usually stop emitting light in seconds.

"The ability to target specific cells in the lung without exposing surrounding cells and tissue or distant organs to the detrimental effects of drugs is an exciting avenue to explore," says Krishnan V. Chakravarthy, PhD, a research fellow in the UB School of Medicine and Biomedical Sciences joint MD/PhD program and lead author on the paper.

"We have been able to prove this in both cultured cells and in animals," he continues. "The technology is still in its infancy, but being able to conduct these experiments in the whole animal makes it more promising as a clinical application. The long-term goal would be to do targeted drug delivery through aerosolized techniques, making it suitable for clinical use."

Researchers in UB's Institute of Lasers, Photonics and Biophotonics have made major advancements in the use of quantum dots, sometimes called artificial atoms, to build new devices for biological and environmental sensing.

In this research, quantum dots were linked with doxorubicin, an anti-cancer chemotherapy drug, to target specific lung cells, known as alveolar macrophages (aMØ) which play a critical role in the pathogenesis of various inflammatory lung injuries.

"The aMØ is the sentinel cell involved in directing the host innate and adaptive immune responses involved in infectious and non-infectious lung diseases such as COPD," notes Chakravarthy. "The aMØ's central role in response to environmental influences makes these cells an ideal candidate for targeted drug delivery to modulate the immune/inflammatory response."

To test the ability of linked quantum dot-doxorubicin (QD-DOX) to decrease lung inflammation, the researchers delivered QD-DOX or doxorubicin alone to rats and mice and assessed the damage to the lung. Doxorubicin, a frequently used cancer drug, is known to cause a variety of damaging immune responses in cancer patients.

Results showed that QD-DOX increased uptake of the drug compared with doxorubicin alone, and did not cause as significant a pro-inflammatory response as doxorubicin alone. The researchers also demonstrated that the drug is released from the QD-DOX formulation once it is delivered into the targeted cell and still retains its bioactivity.

"Based on these results, we believe that linking quantum dots with therapeutic drugs may have tremendous potential for diagnosis and treatment of lung injury compared to other nanoparticle formulations, and should be further developed for lung pharmacotherapy applications," says Chakravarthy.

Additional authors on the paper, all from UB, are Bruce A. Davidson, PhD; Jadwiga D. Helsinki; Hong Ding, PhD; Wing-Cheung Law; Ken-Tye Yong, PhD; Paras N. Prasad, PhD; and Paul Knight, MD, PhD.

The research is supported by grants from the National Institutes of Health to Chakravarthy, Knight and Prasad, and by a grant from John Oishei Foundation to Prasad.


Story Source:

The above story is based on materials provided by University at Buffalo. Note: Materials may be edited for content and length.


Journal Reference:

  1. Krishnan V. Chakravarthy, Bruce A. Davidson, Jadwiga D. Helinski, Hong Ding, Wing-Cheung Law, Ken-Tye Yong, Paras N. Prasad, Paul R. Knight. Doxorubin-conjugated quantum dots to target alveolar macrophages and inflammation. Nanomedicine: Nanotechnology, Biology and Medicine, 2010; DOI: 10.1016/j.nano.2010.09.001

Cite This Page:

University at Buffalo. "Cancer drug linked to quantum dots increases drug uptake, reduces inflammation." ScienceDaily. ScienceDaily, 3 November 2010. <www.sciencedaily.com/releases/2010/11/101101171238.htm>.
University at Buffalo. (2010, November 3). Cancer drug linked to quantum dots increases drug uptake, reduces inflammation. ScienceDaily. Retrieved April 24, 2014 from www.sciencedaily.com/releases/2010/11/101101171238.htm
University at Buffalo. "Cancer drug linked to quantum dots increases drug uptake, reduces inflammation." ScienceDaily. www.sciencedaily.com/releases/2010/11/101101171238.htm (accessed April 24, 2014).

Share This



More Health & Medicine News

Thursday, April 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Big Pharma Braces for M&A Wave

Big Pharma Braces for M&A Wave

Reuters - Business Video Online (Apr. 22, 2014) — Big pharma on the move as Novartis boss, Joe Jimenez, tells Reuters about plans to transform his company via an asset exchange with GSK, and Astra Zeneca shares surge on speculation that Pfizer is looking for a takeover. Joanna Partridge reports. Video provided by Reuters
Powered by NewsLook.com
Study Says Most Crime Not Linked To Mental Illness

Study Says Most Crime Not Linked To Mental Illness

Newsy (Apr. 22, 2014) — A new study finds most crimes committed by people with mental illness are not caused by symptoms of their illness or disorder. Video provided by Newsy
Powered by NewsLook.com
Hagel Gets Preview of New High-Tech Projects

Hagel Gets Preview of New High-Tech Projects

AP (Apr. 22, 2014) — Defense Secretary Chuck Hagel is given hands-on demonstrations Tuesday of some of the newest research from DARPA _ the military's Defense Advanced Research Projects Agency program. (April 22) Video provided by AP
Powered by NewsLook.com
How Smaller Plates And Cutlery Could Make You Feel Fuller

How Smaller Plates And Cutlery Could Make You Feel Fuller

Newsy (Apr. 22, 2014) — NBC's "Today" conducted an experiment to see if changing the size of plates and utensils affects the amount individuals eat. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins